UnitedHealth Group Share Price Rises Amid AI Spend Benefits and Undervaluation Debate

UnitedHealth Group (UNH) has seen its share price climb 18.1% year-to-date, but there's still a question about whether it's undervalued.

The company's Q1 earnings report showed strong results, with some analysts believing the reported $3 billion artificial intelligence spend is starting to deliver benefits for the business.

Despite this, UNH's share price has been choppy in the short term, down 2.4% over the past month and 2.5% over 90 days.

The analysts' consensus price target of $475.23 per share suggests that UnitedHealth Group is currently undervalued by about 16.4%, but there's a wide range of opinions among analysts, with some predicting a price as high as $529.00 and others as low as $313.00.